Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007:2:71-81.
Epub 2007 Mar 6.

Targeting receptors, transporters and site of absorption to improve oral drug delivery

Affiliations

Targeting receptors, transporters and site of absorption to improve oral drug delivery

J H Hamman et al. Drug Target Insights. 2007.

Abstract

Although the oral route of drug administration is the most acceptable way of self-medication with a high degree of patient compliance, the intestinal absorption of many drugs is severely hampered by different biological barriers. These barriers comprise of biochemical and physical components. The biochemical barrier includes enzymatic degradation in the gastrointestinal lumen, brush border and in the cytoplasm of the epithelial cells as well as efflux transporters that pump drug molecules from inside the epithelial cell back to the gastrointestinal lumen. The physical barrier consists of the epithelial cell membranes, tight junctions and mucus layer. Different strategies have been applied to improve the absorption of drugs after oral administration, which range from chemical modification of drug molecules and formulation technologies to the targeting of receptors, transporters and specialized cells such as the gut-associated lymphoid tissues. This review focuses specifically on the targeting of receptor-mediated endocytosis, transporters and the absorption-site as methods of optimizing intestinal drug absorption. Intestinal epithelial cells express several nutrient transporters that can be targeted by modifying the drug molecule in such a way that it is recognized as a substrate. Receptor-mediated endocytosis is a transport mechanism that can be targeted for instance by linking a receptor substrate to the drug molecule of interest. Many formulation strategies exist for enhancing drug absorption of which one is to deliver drugs at a specific site in the gastrointestinal tract where optimum drug absorption takes place.

Keywords: Oral drug delivery; absorption enhancement; active transporters; receptor-mediated endocytosis; site-specific drug delivery.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematical illustration of the barrier properties of the intestinal mucosa. A) The physical barrier includes the tight junctions that limit paracellular transport and the epithelial cell membrane that limits the transcellular transport and B) The biochemical barrier includes brush border and/or intracellular metabolism and apical polarized efflux (with permission from Pauletti et al. 1996).

Similar articles

Cited by

References

    1. Ambudkar SV, Kim IW, Sauna ZE. The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1) Eur J Pharm Sci. 2006;27:392–400. - PubMed
    1. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 1993;82(10):979–87. - PubMed
    1. Aungst BJ. Intestinal permeation enhancers. J. Pharm. Sci. 2000;89(4):429–42. - PubMed
    1. Banerjee D, Flanagan PR, Cluett J, et al. Transferrin receptors in the human gastrointestinal tract. Gastroenterology. 1986;91:861–9. - PubMed
    1. Bardonnet PL, Faive V, Pugh WJ, et al. Gastroretentive dosage forms: Overview and special case of Helicobacter Pilori. J. Control Release. 2006;111:1–18. - PubMed

LinkOut - more resources